Seven Fleet Capital Management’s Soleno Therapeutics SLNO Stock Holding History

Seven Fleet Capital Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-115,770	Closed	-$3.88M	–	115
2026 Q1	$3.88M	Sell	115,770 -14,309	-11%	-$561K	1.22%	20
2025 Q4	$6.02M	Buy	+130,079	New	+$7.13M	4.08%	3

Seven Fleet Capital Management's SLNO Position: Q2 2026 in Review

Seven Fleet Capital Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 115,770 shares — an estimated $3.88M sold.

Seven Fleet Capital Management first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $6.02M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Seven Fleet Capital Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Seven Fleet Capital Management sold 115,770 Soleno Therapeutics shares in Q2 2026, an estimated $3.88M.
Seven Fleet Capital Management first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
Seven Fleet Capital Management's Soleno Therapeutics position peaked at $6.02M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.